IGFBP5 and central nervous system cancer: To investigate the effect of IGFBP5 on the prognosis of glioma, patients with glioma were divided into low- and high groups according to IGFBP5 expression.The results showed the distribution of risk scores and and the number of deaths were higher in the high-risk score group than in the low-risk score group in the glioma dataset (Figure 2A).